Sign In
Buy MIRM
$122.13
-5.57 (-4.36%)
At Close: Jul 10, 2026
Xconomy: Genmab, Mirum Pharma & Fulcrum Raise $653M in Wall Street Debuts
01:01pm, Thursday, 18'th Jul 2019
Initial public offerings took a brief summer break the week of Independence Day, but healthcare IPO activity resumed this week as three more companies
Mirum Pharmaceuticals Announces Pricing of Initial Public Offering
10:33pm, Wednesday, 17'th Jul 2019
FOSTER CITY, Calif., July 17, 2019 /PRNewswire/ -- Mirum Pharmaceuticals, Inc., a clinical-stage therapeutics company developing a novel approach for treating cholestatic liver diseases, today announ
Xconomy: Reneo Pharma Launches with $50M to Target Energy-Depleting Diseases
10:16pm, Monday, 20'th May 2019
Yet another new biotech company has been founded in San Diego by serial entrepreneur Mike Grey and other alumni of rare disease startup Lumena
